Owner Maxygen Holdings Ltd.

Inventors Jensen, Anne Dam

Agent Spruson & Ferguson

Pub. Number AU-B-2002252971

PCT Pub. Number WO2002/081507

Priority PA 2002 00198 11.02.02 DK; PA 2001 00579 06.04.01 DK; 10/116,273 04.04.02 US; PA 2001 00714 07.05.01 DK

Filing date 4 April 2002

Wipo publication date 21 October 2002

Acceptance publication date 29 November 2007

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

C07K 14/57 (2006.01) Peptides having more than 20 amino acids

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione